- FDA Expands Ribociclib Indication in HR-positive, HER2-negative Advanced or Metastatic Breast Cancer
- EMA PRAC Recommends Restricting Use of Prostate Cancer Medicine Radium-223 Dichloride
- ESMO Releases New Patient Guide in Breast Cancer
- FDA Broadens Approval for Enzalutamide to Include Non-Metastatic Castration-Resistant Prostate Cancer
- NICE Issues Guideline for Primary Brain Tumours and Brain Metastases in Adults
- A Comprehensive Catalogue of Stromal Cells in Human Lung Tumours at Single-Cell Resolution
Matthew M Poppe
Assistant Professor, Department of Radiation Oncology, University of Utah, Salt Lake City, Utah, US
Authored articles:
European Oncology & Haematology
Citation override:
European Oncology & Haematology, 2013;9(2):119–23
Oncology & Hematology Review (US)
Citation override:
Oncology & Hematology Review, 2014;10(1):61–5